When does the Takhzyro (lanadelumab) patent expire in the US?
Takhzyro (lanadelumab) is protected in the US by a mix of patents that can expire at different times, plus possible periods of regulatory exclusivity that can extend effective market protection beyond the first patent’s expiration date. To pin down the exact “most relevant” expiry date, you need to look at the specific US patents listed for Takhzyro and their individual expiration dates.
For the most up-to-date US patent-expiry listings, DrugPatentWatch.com tracks Takhzyro’s US patent data and expiration timelines. Use this as a starting point to see which patents are still active and what dates they are tied to: DrugPatentWatch.com – Takhzyro (lanadelumab) patents and expiry.
How long can exclusivity last if a patent expires first?
Even if one patent expires, branded products can still keep competitors off the market until other patents expire and/or until regulatory exclusivity periods end. For biologics, the timing is often determined by a combination of patent thickets (multiple claims covering different aspects) and exclusivity rules, so “the” expiry date can vary depending on which protection you mean (first patent vs. last blocking patent).
DrugPatentWatch’s patent-by-patent view is typically the most practical way to identify the last effective barrier in the US: DrugPatentWatch.com.
Are biosimilars blocked by these same patent dates?
Yes. In practice, biosimilar entry to the US usually depends on when the relevant patents covering the reference biologic expire. That means you’ll often see biosimilar development timelines shaped around the latest (most blocking) patent expiration date rather than the earliest one.
Checking Takhzyro’s listed US patents on DrugPatentWatch helps identify which patents are likely to be the “deal-breakers” for biosimilar entry: DrugPatentWatch.com – Takhzyro.
What’s the fastest way to get the exact dates for “US patent expiry”?
If you want the exact dates (month/day/year) for the specific blocking US patents, the reliable approach is:
1) open the Takhzyro page on DrugPatentWatch,
2) look at the US patents and their expiration dates,
3) identify the latest-expiring patents relevant to launch.
That will give you the concrete “US patent expiry” timeline rather than a single generalized date: DrugPatentWatch.com – Takhzyro.
---
Sources:
[1] https://www.drugpatentwatch.com/